Contrast agents for MR imaging of the liver

Radiologic Clinics of North America

Volumn 43, Issue 5 SPEC. ISS., 2005, Pages 887-898

  Balci, N Cem ^a   Semelka, Richard C ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOBENATE DIMEGLUMINE; GADOXETIC ACID; MANGAFODIPIR;

CONTRAST ENHANCEMENT; HUMAN; LIVER CELL; LIVER CIRRHOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; REVIEW;

EID: 23744493452     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rcl.2005.05.004     Document Type: Review

References (43)

1. R.C. Semelka, and T.K. Helmberger Contrast agents for MR imaging of the liver Radiology 218 2001 27 38
2. F.M. Cavagna, M. Dapra, and P.M. Castelli Trends and developments in MRI contrast agent research Eur Radiol 7 Suppl 5 1997 222 224
3. J.P. Earls, N.M. Rofsky, and D.R. DeCorato Hepatic arterial-phase dynamic enhanced MR imaging: optimization with a test examination and a power injector Radiology 202 1997 268 273
4. J.A. Webb, H.S. Thomsen, and S.K. Morcos The use of iodinated and gadolinium contrast media during pregnancy and lactation Eur Radiol 15 6 2005 1234 1240
5. R.C. Semelka, S. Worawattankul, and N.L. Kelekis Liver lesion detection, characterization, and effect on patient management: comparison of single phase spiral CT and current MR techniques J Magn Reson Imaging 7 1997 1040 1047
6. R.C. Semelka, D.R. Martin, and N.C. Balci Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement J Magn Reson Imaging 13 2001 397 401
7. W.S. Whitney, R.J. Herfkens, and R.B. Jeffrey Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hemangiomas from malignancies at 1.5 T Radiology 189 1993 863 870
8. B. Hamm, A.E. Mahfouz, and M. Taupitz Liver metastases: improved detection with dynamic gadolinium-enhanced MR imaging? Radiology 202 1997 677 682
9. P. Reimer, S. Saini, and K.K. Kwong Dynamic gadolinium-enhanced echo-planar MR imaging of the liver: effect of pulse sequence and dose on enhancement J Magn Reson Imaging 4 1994 331 335
10. P. Reimer, G. Schneider, and W. Schima Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications Eur Radiol 14 2004 559 578
11. C. Wang Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas Acta Radiol Suppl 415 1998 1 31
12. C. Wang, H. Ahlstrom, and S. Ekholm Diagnostic efficacy of MnDPDP in MR imaging of the liver: a phase III multicentre study Acta Radiol 38 1997 643 649
13. K.P. Aicher, M. Laniado, and A.F. Kopp Mn-DPDP-enhanced MR imaging of malignant liver lesions: efficacy and safety in 20 patients J Magn Reson Imaging 3 1993 731 737
14. C. Bartolozzi, F. Donati, and D. Cioni MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis Eur Radiol 10 2000 1697 1702
15. L. Marti-Bonmati, A.F. Fog, and B.O. de Beeck Safety and efficacy of mangafodipir trisodium in patients with liver lesions and cirrhosis Eur Radiol 13 2003 1685 1692
16. C. de Haen, V. Lorusso, and F. Luzzani Hepatic transport of gadobenate dimeglumine in TR-rats Acad Radiol 3 1996 S452 S454
17. M.A. Kirchin, G. Pirovano, and C. Venetianer Gadobenate dimeglumine (Gd-BOPTA), an overview Invest Radiol 33 1998 798 809
18. A. Spinazzi, V. Lorusso, and G. Pirovano Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers Acad Radiol 6 1999 282 291
19. C. de Haen, and L. Gozzini Solubletype hepatobiliary contrast agents for MR imaging J Magn Reson Imaging 3 1993 179 186
20. W. Schima, J. Petersein, and P.F. Hahn Contrast enhanced MR imaging of the liver: comparison between Gd-BOPTA and Mangafodipir J Magn Reson Imaging 7 1997 130 135
21. C. de Haen, R. La Ferla, and F. Maggioni Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) as contrast agent for magnetic resonance imaging of the liver: mechanistic studies in animals J Comput Assist Tomogr 23 1999 S169 S179
22. F.M. Cavagna, F. Maggioni, and P.M. Castelli Gadolinium chelates with weak binding to serum proteins: a new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging Invest Radiol 32 1997 780 796
23. G. Schuhmann-Giampieri Liver contrast media for magnetic resonance imaging: interrelations between pharmacokinetics and imaging Invest Radiol 28 1993 753 761
24. A. Spinazzi, V. Lorusso, and G. Pirovano Multihance clinical pharmacology: biodistribution and MR enhancement of the liver Acad Radiol 5 Suppl 1 1998 S86 S89 [discussion: S93-4]
25. C. Powers, P.R. Ros, and C. Stoupis Primary liver neoplasms: MR imaging with pathologic correlation Radiographics 14 1994 459 482
26. A.E. Mahfouz, B. Hamm, and K.J. Wolf Peripheral washout: a sign of malignancy on dynamic gadolinium enhanced MR images of focal liver lesions Radiology 190 1994 49 52
27. R.C. Semelka, E.D. Brown, and S.M. Ascher Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images Radiology 192 1994 401 406
28. B. Hamm, R.F. Thoeni, and R.G. Gould Focal liver lesions: characterization with nonenhanced and dynamic contrast material enhanced MR imaging Radiology 190 1994 417 423
29. B. Hamm, A.E. Mahfouz, and M. Taupitz Liver metastases: improved detection with dynamic gadolinium-enhanced MR imaging? Radiology 202 1997 677 682
30. R. Kuwatsuru, M. Kadoya, and K. Ohtomo Comparison of gadobenate dimeglumine with gadopentetate dimeglumine for magnetic resonance imaging of liver tumors Invest Radiol 36 2001 632 641
31. J. Petersein, A. Spinazzi, and A. Giovagnoni Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging: a multicenter phase III clinical study Radiology 215 2000 727 736
32. G. Schneider, R. Maas, and L. Schultze Kool Low-dose gadobenate dimeglumine versus standard dose gadopentetate dimeglumine for contrast-enhanced magnetic resonance imaging of the liver: an intraindividual crossover comparison Invest Radiol 38 2003 85 94
33. G. Morana, L. Grazioli, and G. Schneider Hypervascular hepatic lesions: dynamic and late enhancement pattern with Gd-BOPTA Acad Radiol 9 Suppl 2 2002 476 479
34. L. Grazioli, G. Morana, and M.A. Kirchin MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intraindividual comparison J Magn Reson Imaging 17 2003 593 602
35. H.J. Weinmann, G. Schuhmann-Giampieri, and H. Schmitt-Willich A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI Magn Reson Med 22 1991 233 237
36. G. Schuhmann-Giampieri, H. Schmitt-Willich, and W.R. Press Preclinical evaluation of Gd-EOBDTPA as a contrast agent in MR imaging of the hepatobiliary system Radiology 183 1992 59 64
37. B. Hamm, T. Staks, and A. Muhler Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging Radiology 195 1995 785 792
38. P. Reimer, E.J. Rummeny, and K. Shamsi Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence Radiology 199 1996 177 183
39. Shamsi K. Gd-EOB-DTPA (Eovist), a liver specific contrast agent for MRI: results of a placebo controlled, double blind dose ranging study in patients with focal liver lesions. Presented at the Tenth scientific meeting and exhibition of the International Society for Magnetic Resonance in Medicine. Honolulu, Hawaii, May 18-24, 2002
40. A. Huppertz, T. Balzer, and A. Blakeborough Improved detection of focal liver lesions in MRI: a multicenter comparison of Gd-EOB-DTPA with intraoperative findings Radiology 230 2004 266 275
41. M.F. Bellin, S. Zaim, and E. Auberton Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging Radiology 193 1994 657 663
42. T.C. Winter III, P.C. Freeny, and H.V. Nghiem MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions AJR Am J Roentgenol 161 1993 1191 1198
43. R. Weissleder, G. Elizondo, and J. Wittenberg Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging Radiology 175 1990 489 493